US EPA CCL 6: Impact on Drinking Water Regulation
On 2 April 2026, the US Environmental Protection Agency released its draft Sixth Contaminant Candidate List (CCL 6) under the Safe Drinking Water Act (SDWA), formally elevating microplastics and pharmaceuticals to priority contaminant groups for the first time in the programme’s history. This is a landmark shift in how federal regulators classify and track substances of concern in drinking water supplies. The CCL is a structured watch list that informs future regulatory decision-making, and while it does not itself impose enforceable limits on public water systems, it formally directs federal research effort and funding toward these contaminant classes.
Concurrent with the CCL 6 announcement, the Advanced Research Projects Agency for Health (ARPA-H), operating under the US Department of Health and Human Services (HHS), unveiled the STOMP initiative (Systematic Targeting Of MicroPlastics), a two-phase programme backed by USD 144 million (approximately AUD 228 million at current exchange rates). STOMP is structured around Phase 1, which targets measurement of microplastics in human tissues and investigation of mechanisms of harm, and Phase 2, which focuses on removal technologies. The scale and structure of this programme signals that the US federal government is treating microplastics as a serious public health issue requiring coordinated scientific effort, not simply a precautionary watch item.
For Australian environmental professionals, water utilities, developers, and local government, this development carries real forward-looking significance. US EPA regulatory frameworks have historically preceded and influenced global water quality standards and analytical methodologies, including those adopted or referenced in Australian practice. The CCL 6 announcement is a signal that microplastics and pharmaceutical contaminants are moving from the scientific literature into the regulatory mainstream, and Australian practitioners would be well served by beginning to factor these substances into long-term planning, conceptual site models, and client risk advice now, ahead of any domestic regulatory response.
US EPA CCL 6 and STOMP Programme
The CCL 6 draft list now contains four priority chemical contaminant groups: PFAS, disinfection byproducts, microplastics, and pharmaceuticals. Notably, cyanotoxins, which were included as a chemical group in CCL 5, have been removed from CCL 6, keeping the total number of chemical groups at four rather than expanding it. This is a meaningful distinction because it demonstrates that the CCL process involves active reassessment and reprioritisation, not simply accumulation. The removal of cyanotoxins does not mean they are no longer of concern; it reflects a determination that they no longer require the same level of priority attention within this particular federal mechanism at this time.
The CCL process under the SDWA requires the US EPA to identify contaminants that are not currently subject to any proposed or promulgated national primary drinking water regulation, that are known or anticipated to occur in public water systems, and that may require regulation under the SDWA. Critically, CCL listing does not impose any requirements on public water systems and does not establish enforceable thresholds. Historically, very few contaminants that have appeared on CCL lists have progressed to regulated status in the short to medium term. The CCL is best understood as a prioritisation mechanism that enables the EPA to direct research funding and monitoring programmes toward contaminants that may eventually warrant a Maximum Contaminant Level (MCL) or treatment technique standard.
The inclusion of microplastics is particularly significant given the state of the science. Microplastics have been detected in human blood, breast milk, lung tissue, and various organs in multiple peer-reviewed studies over the past several years, yet they remain almost entirely unregulated in drinking water standards globally. The STOMP programme addresses the measurement gap directly: current analytical methods for quantifying microplastics in biological and environmental matrices are not standardised, making it difficult to establish dose-response relationships or defensible regulatory thresholds. Phase 1 of STOMP is designed to build that evidentiary foundation, while Phase 2 targets practical removal solutions for drinking water treatment infrastructure.
Pharmaceuticals represent a separate but equally complex challenge. Pharmaceutical compounds enter water supplies through multiple pathways, including human excretion, improper disposal of medications, agricultural use of veterinary medicines, and discharge from manufacturing facilities. The concern is not simply the presence of individual compounds, but the potential for mixture toxicity and the development of antimicrobial resistance in receiving environments. Unlike microplastics, pharmaceutical compounds are chemically diverse and behave very differently in the environment, which makes developing a single regulatory framework for them technically demanding. The CCL 6 designation acknowledges this complexity by grouping them as a class for prioritised research attention rather than singling out specific compounds for immediate regulation.
Implications for Australian Drinking Water Quality Frameworks
Australia’s primary framework for drinking water quality is the Australian Drinking Water Guidelines (ADWG), the most recent version of which was updated in June 2025 and is published by the National Health and Medical Research Council (NHMRC). The ADWG does not currently include guideline values for microplastics or pharmaceutical compounds as regulated contaminants. The World Health Organisation (WHO) published a report on microplastics in drinking water in 2019 that concluded available evid
Background and context
US EPA Adds Microplastics and Pharmaceuticals to Priority Drinking Water Contaminant List (CCL 6)
In a major regulatory shift, the US Environmental Protection Agency (EPA) announced on 2 April 2026 that it is officially adding microplastics and pharmaceuticals to its draft Sixth Contaminant Candidate List (CCL 6) for drinking water. This marks the first time in the program's history that microplastics AND pharmaceuticals have been elevated to priority contaminant groups. However, it should be noted that CCL 6 also removes cyanotoxins as a chemical group (which was included in CCL 5), so the total number of contaminant groups remains four. The prior CCL 5 included PFAS, disinfection byproducts, and cyanotoxins as the three groups.
Concurrently, ARPA-H (Advanced Research Projects Agency for Health), an agency within HHS, unveiled the $144 million STOMP (Systematic Targeting Of MicroPlastics) initiative. STOMP is not a direct HHS departmental program — it is run under ARPA-H. Additionally, the program's stated goals are measurement, researching mechanisms of harm, AND removal — not merely developing 'methods to remove'. The program operates in two phases: Phase 1 (Measurement & Mechanism) and Phase 2 (Removal).
Did you know? Despite microplastics being increasingly detected in human blood, breast milk, and organs, they have remained largely unregulated in global drinking water standards. The CCL designation unlocks focused federal research and funding, but it does NOT itself establish a direct pathway to enforceable regulatory thresholds. CCL listing does not impose any requirements on public water systems, and historically very few CCL contaminants have progressed to regulated status. The CCL is best described as a 'watch list' that may eventually inform future regulation — not a committed step toward enforceable thresholds.
Why it Matters for Australian Environmental Professionals
While this is a US regulatory action, the EPA’s CCL updates historically set the precedent for global water quality standards and analytical testing methodologies. Australian environmental consultants, hydrogeologists, and water utilities must pay close attention to this development.
References and related sources
- Primary source: www.food-safety.com
- food-safety.com
- NEPM Assessment of Site Contamination
- Australian Drinking Water Guidelines
How iEnvi can help
iEnvi provides specialist consulting services relevant to this topic. Our team includes CEnvP Site Contamination Specialists with experience across contaminated land, groundwater, remediation, ecology, and regulatory compliance.
- iEnvi remediation services
- iEnvi groundwater services
- iEnvi expert services and independent review services
This is an iEnvi Machete news summary. Prepared by iEnvi to summarise the source article for contaminated land, groundwater, remediation, approvals and site risk professionals.
Published: 03 Apr 2026
Need advice on this topic? Speak to an iEnvi expert at hello@ienvi.com.au or 1300 043 684, or contact us online.
Need advice on this issue? iEnvi provides practical, senior-led environmental consulting across contaminated land, remediation, ecology and environmental risk.
Contaminated land advice Remediation services Groundwater services Ecology consulting Talk to iEnvi